BRIEF published on 01/12/2026 at 15:01, 3 months 25 days ago Eckert & Ziegler participeront à la conférence JP Morgan Healthcare Conférence Sur Les Soins De Santé JP Morgan Eckert Et Ziegler Composants Isotopiques Radiopharmaceutique
BRIEF published on 01/12/2026 at 15:01, 3 months 25 days ago Eckert & Ziegler to Attend J.P. Morgan Healthcare Conference Eckert & Ziegler Healthcare Conference J.P. Morgan Radiopharmaceutical Isotope Components
PRESS RELEASE published on 01/12/2026 at 14:56, 3 months 25 days ago Eckert & Ziegler to Participate in the 44th Annual J.P. Morgan Healthcare Conference Eckert & Ziegler SE to participate in the 44th Annual J.P. Morgan Healthcare Conference. Dr. Harald Hasselmann, CEO, will present on 14 January 2026 in San Francisco, CA Healthcare Conference Eckert & Ziegler SE J.P. Morgan Healthcare Conference Dr. Harald Hasselmann
BRIEF published on 01/08/2026 at 09:05, 3 months 29 days ago Eckert et Ziegler : Un argument convaincant en faveur de l’investissement malgré la volatilité des marchés Croissance Investissement Produits Radiopharmaceutiques Performance Boursière Radio-isotopes
BRIEF published on 01/08/2026 at 09:05, 3 months 29 days ago Eckert & Ziegler: A Strong Case for Investment Amidst Market Volatility Investment Growth Radiopharmaceuticals Stock Performance Radioisotopes
PRESS RELEASE published on 01/08/2026 at 09:00, 3 months 29 days ago Original-Research: Eckert & Ziegler SE (von NuWays AG): BUY Initiation research by NuWays AG recommends buying Eckert & Ziegler SE (DE0005659700) with a target price of EUR 23, citing growth in targeted radiopharmaceuticals market and unique business positioning Buy Recommendation Target Price Eckert & Ziegler SE Radiopharmaceuticals Initiation Research
BRIEF published on 12/05/2025 at 16:15, 5 months 1 day ago Executive Board Restructuring at Eckert & Ziegler Executive Board Eckert & Ziegler Restructuring Nuclear Medicine Isotope Products
BRIEF published on 12/05/2025 at 16:15, 5 months 1 day ago Restructuration du conseil d'administration chez Eckert & Ziegler Conseil D'administration Restructuration Médecine Nucléaire Produits Isotopiques Eckert Et Ziegler
PRESS RELEASE published on 12/05/2025 at 16:10, 5 months 1 day ago Reorganization of the Eckert & Ziegler Executive Board Eckert & Ziegler SE to reorganize Executive Board, reducing from three to two members, effective January 1, 2026. Frank Yeager's contract to end on Dec 31, 2025, continuing in Isotope Products role Executive Board Reorganization Eckert & Ziegler SE Isotope Products Frank Yeager
BRIEF published on 12/03/2025 at 09:05, 5 months 3 days ago Eckert & Ziegler and SK Biopharmaceuticals Form Actinium-225 Partnership Oncology Eckert & Ziegler Radiopharmaceuticals Actinium-225 SK Biopharmaceuticals
Published on 05/07/2026 at 02:00, 3 hours 41 minutes ago Lobe Sciences Ltd. Announces Participation in the D. Boral Capital Global Conference in New York
Published on 05/06/2026 at 23:30, 6 hours 11 minutes ago Stabilis Solutions Announces First Quarter 2026 Results
Published on 05/06/2026 at 23:05, 6 hours 36 minutes ago Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity
Published on 05/06/2026 at 23:00, 6 hours 41 minutes ago Green Bridge Metals Strengthens Technical and Strategic Team as 2026 Work Programs Advance
Published on 05/06/2026 at 22:10, 7 hours 31 minutes ago Banyan Gold Announces Closing of $46.5 Million Private Placement
Published on 05/07/2026 at 04:00, 1 hour 41 minutes ago L’Université chinoise de Hong Kong (CUHK) se classe en tête à Hong Kong et en Asie dans le dernier classement mondial des universités par discipline publié par QS (Quacquarelli Symonds)
Published on 05/07/2026 at 04:00, 1 hour 41 minutes ago CUHK Claims Top Positions in Hong Kong and Asia in the Latest QS World University Rankings by Subject
Published on 05/07/2026 at 03:50, 1 hour 51 minutes ago 450 MHz LTE: Stronger, Smarter Grid for Brazil
Published on 05/07/2026 at 00:47, 4 hours 54 minutes ago Blue Cap AG expands portfolio through the acquisition of Janoschka AG
Published on 05/07/2026 at 00:43, 4 hours 57 minutes ago EQS-Adhoc: Blue Cap AG Acquires Janoschka AG and Adjusts Forecast Due to Transaction
Published on 05/06/2026 at 18:00, 11 hours 41 minutes ago Mise à disposition des documents relatifs à l'AG du 4 juin 2026
Published on 05/06/2026 at 18:00, 11 hours 41 minutes ago Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
Published on 05/06/2026 at 18:00, 11 hours 41 minutes ago Information concerning the total number of voting rights and shares in the share capital as of April 30, 2026
Published on 05/06/2026 at 18:00, 11 hours 41 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 30 avril 2026
Published on 05/06/2026 at 17:45, 11 hours 56 minutes ago Information concerning the total number of voting rights and shares 2026 04 30
